当前位置:
X-MOL 学术
›
Human Psychopharmacology: Clinical and Experimental
›
论文详情
Our official English website, www.x-mol.net, welcomes your
feedback! (Note: you will need to create a separate account there.)
The safety of agomelatine in standard medical practice in depressed patients: A 26-week international multicentre cohort study.
Human Psychopharmacology: Clinical and Experimental ( IF 1.672 ) Pub Date : 2020-09-25 , DOI: 10.1002/hup.2759 Philip Gorwood 1 , Jacques Benichou 2 , Nicholas Moore 3 , Enric Álvarez Martínez 4 , Joost Mertens 5 , Eugenio Aguglia 6 , Maria-Luisa Figueira 7 , Peter Falkai 8 , Valérie Olivier 9 , Marine Wattez 9 , Françoise Picarel-Blanchot 9 , Christian de Bodinat 9
Human Psychopharmacology: Clinical and Experimental ( IF 1.672 ) Pub Date : 2020-09-25 , DOI: 10.1002/hup.2759 Philip Gorwood 1 , Jacques Benichou 2 , Nicholas Moore 3 , Enric Álvarez Martínez 4 , Joost Mertens 5 , Eugenio Aguglia 6 , Maria-Luisa Figueira 7 , Peter Falkai 8 , Valérie Olivier 9 , Marine Wattez 9 , Françoise Picarel-Blanchot 9 , Christian de Bodinat 9
Affiliation
The present observational cohort study documented the safety of agomelatine in current medical practice in out‐patients suffering from major depressive disorder.
中文翻译:
阿戈美拉汀在抑郁症患者标准医疗实践中的安全性:一项为期 26 周的国际多中心队列研究。
本观察性队列研究记录了阿戈美拉汀在当前医疗实践中对患有重度抑郁症的门诊患者的安全性。
更新日期:2020-09-25
中文翻译:
阿戈美拉汀在抑郁症患者标准医疗实践中的安全性:一项为期 26 周的国际多中心队列研究。
本观察性队列研究记录了阿戈美拉汀在当前医疗实践中对患有重度抑郁症的门诊患者的安全性。